2025. Long-term Safety and Efficacy of Belzutifan in Von Hippel–Lindau Syndrome: A VHL Coordinating Care Center Experience. Journal of Kidney Cancer. 12, 3 (Sep. 2025), 25–31. DOI:https://doi.org/10.15586/jkcvhl.v12i3.425.